Details for New Drug Application (NDA): 088021
✉ Email this page to a colleague
The generic ingredient in BONTRIL is phendimetrazine tartrate. There are five drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the phendimetrazine tartrate profile page.
Summary for 088021
Tradename: | BONTRIL |
Applicant: | Valeant |
Ingredient: | phendimetrazine tartrate |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE, EXTENDED RELEASE;ORAL | Strength | 105MG | ||||
Approval Date: | Sep 21, 1982 | TE: | RLD: | No |
Complete Access Available with Subscription